Contemporary insights into painful diabetic neuropathy and treatment with spinal cord stimulation (Q37954530)

25 August 2017

Contemporary insights into painful diabetic neuropathy and treatment with spinal cord stimulation (English)

1 reference

25 August 2017

1 reference

Kai McGreevy

1

1 reference

PubMed ID

22071956

25 August 2017

Kayode A Williams

series ordinal

2

1 reference

PubMed ID

22071956

25 August 2017

language of work or name

English

0 references

publication date

1 February 2012

1 reference

Current Pain and Headache Reports

25 August 2017

1 reference

25 August 2017

16

1 reference

25 August 2017

1

1 reference

25 August 2017

43-49

1 reference

https://scigraph.springernature.com/pub.10.1007/s11916-011-0230-2

25 August 2017

0 references

cites work

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Diabetic neuropathy: clinical features, etiology, and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Polyol pathway and diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Effect of zenarestat, an aldose reductase inhibitor, on endoneurial blood flow in experimental diabetic neuropathy of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Beta3, a novel auxiliary subunit for the voltage gated sodium channel is upregulated in sensory neurones following streptozocin induced diabetic neuropathy in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

The spectrum of neuropathy in diabetes and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Pain mechanisms: a new theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Attenuation of neuropathic pain by segmental and supraspinal activation of the dorsal column system in awake rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Sensory fibers containing vanilloid receptor-1 (VR-1) mediate spinal cord stimulation-induced vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Extracellular signal-regulated kinase (ERK) and protein kinase B (AKT) pathways involved in spinal cord stimulation (SCS)-induced vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Release of gamma-aminobutyric acid in the dorsal horn and suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Cholinergic mechanisms involved in the pain relieving effect of spinal cord stimulation in a model of neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Gamma-aminobutyric acid is released in the dorsal horn by electrical spinal cord stimulation: an in vivo microdialysis study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Effect and safety of spinal cord stimulation for treatment of chronic pain caused by diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Decreased insulin requirements with spinal cord stimulation in a patient with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

Improved glucose tolerance and insulin sensitivity after electrical stimulation-assisted cycling in people with spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0230-2

What does the mechanism of spinal cord stimulation tell us about complex regional pain syndrome?

21 January 2018

1 reference

12 December 2020

Painful diabetic neuropathy: advantage of novel drugs over old drugs?

1 reference

12 December 2020

Nitric oxide synthase inhibition attenuates vasoactive response to spinal cord stimulation in an experimental cerebral vasospasm model

1 reference

12 December 2020

Cutaneous vasodilation during dorsal column stimulation is mediated by dorsal roots and CGRP.

1 reference

12 December 2020

Pregabalin as a treatment for painful diabetic peripheral neuropathy: a meta-analysis

1 reference

12 December 2020

Impaired inhibitory G-protein function contributes to increased calcium currents in rats with diabetic neuropathy

1 reference

12 December 2020

The natural history of chronic painful peripheral neuropathy in a community diabetes population

1 reference

12 December 2020

The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

10.1007/S11916-011-0230-2

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

22071956